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Summary The relative risk of subsequent cancers was evaluated for a total of 9,092 patients with lip and
oropharyngeal cancer recorded between 1953 and 1989 in the nationwide Finnish Cancer Registry. The
observed numbers of patients were compared with those expected on the basis of the incidence rates in the
Finnish population. There were 1,130 patients (12%) with a new cancer. The standardised incidence ratio
(SIR) of contracting a new primary cancer was 1.2 for lip cancer patients (95% CI 1.1-1.3) and 1.4 for
patients with oropharyngeal cancer (95% CI 1.2-1.4). Among lip cancer patients, a statistically significant
excess risk was found for subsequent cancers in the oropharyngeal area (SIR 1.9, 95% CI 1.1-3.1), larynx
(SIR 2.0, 95% CI 1.2-2.9) and lung (SIR 1.4, 95% CI 1.3-1.6), i.e. for cancers with tobacco aetiology.
Among patients with oropharyngeal cancer there was an excess of lip cancer (SIR, 3.5, 95% CI 1.5-6.9), lung
cancer (SIR 1.8, 95% CI 1.3-2.3) and leukaemia (SIR 2.3, 95% CI 1.0-4.3). Radiotherapy for the first
primary did not increase the risk of new cancer.
As cancer treatment has become more effective, multiple
primary cancers have become a diagnostic, therapeutic and
prognostic problem. Multiple primary tumours have been
reported in up to one-third of patients with oral cancer. The
relative risk of a second cancer in the oral cavity or lung has
been reported to be especially high (Berg et al., 1970;
Schoenberg & Myers, 1977; Gluckman et al., 1980; Tepper-
man & Fitzpatrick, 1981; Black et al., 1983; Lyons et al.,
1986; Gratz & Makek, 1990; de Vries & Gluckman, 1991;
Donath et al., 1992).
In many multiple cancer studies the numbers of patients
with a new primary cancer have been small. Some studies
have included both synchronous (occurring within an interval
of 6 months) and metachronous (excluding cases diagnosed
within an interval of less than 6 months) multiple cancers.
Problems have also been encountered with respect to follow-
up of the patients, distinction between recurrence and new
primary cancer and statistical analyses of risks of second
primary cancers (Schoenberg & Myers, 1977; Tepperman &
Fitzpatrick, 1981; Kegel & Schmieder, 1982; Shikhani et al.,
1986; de Vries et al., 1986; Shibuya et al., 1987; Gitt et al.,
1989; Panosetti et al., 1989; Day & Blot, 1992).
The aim of our study was to evaluate the relative risks of
new cancers among patients with cancer of the lip or oro-
pharynx on the basis of reliable nationwide population-based
data.
Material and methods
The series consisted of all patients with cancer of the lip
(ICD-7 code 140) and oropharynx (ICD-7 codes 141,
143-145, 147-148) diagnosed between 1953 and 1989 in
Finland and recorded in the files of the Finnish Cancer
Registry. Patients with cancers of the salivary glands and
nasopharynx were not included.
Subsequent new cancers in these patients were sought in
the Cancer Registry files and tabulated according to sex, site
of the first cancer, site, age and year of diagnosis of the
second cancer and interval between the first and second
cancer. The first 6 months after diagnosis of the first cancer
was excluded from both the person-years at risk and
numbers of cancers subsequently observed. The follow-up
ended at the date of death or emigration, or on December 31
1989, whichever came first. Complete follow-up was
achieved. The patients were divided into two age groups:
0-49 years and 50 + years at the time of diagnosis of the
first cancer. Patients who received radiotherapy were com-
pared with those who did not.
Expected numbers of cases were calculated on the basis of
the person-years at risk and age, calendar period and sex-
specific incidence rates in the Finnish population. Standar-
dised incidence ratios (SIRs) were defined as ratios of
observed to expected numbers of cases. The 95% confidence
intervals of the SIRs were defined assuming that the observed
numbers of cases followed a Poisson distribution.
Results
A total of 9,092 patients with lip and oropharyngeal cancer
(excluding those with a follow-up period of less than 6
months) were recorded in the Finnish Cancer Registry
between 1953 and 1989 (Table I). Male lip cancer pre-
dominated (55% of patients) and - because of the good
survival of lip cancer patients - accounted for an even larger
proportion of the patient-years during follow-up.
During the follow-up, 1,130 subsequent primary cancers
were recorded (Table II). The SIR of contracting a new
primary cancer was 1.2 for patients with lip cancer and 1.4
for those with oropharyngeal cancer. The risk of new cancer
was statistically significantly elevated in both men and
women. In women, the highest relative risks of a subsequent
cancer were noted among patients with cancer of the tongue
(1.8) and in men with cancer of the tongue or pharynx (1.4
for both). The only group for which the risk of subsequent
cancer was not elevated was women with cancer of the
pharynx.
Lip and tongue cancer patients under 50 years of age
experienced a higher relative risk of a subsequent cancer than
did older patients (Table II). The relative risk of a subse-
quent cancer was highest for young women with primary
cancer of the tongue (observed 10, expected 2.7, SIR 3.7,
95% CI 1.8-6.8).
For patients with lip cancer a statistically significant excess
risk was recorded for cancer of the larynx (SIR 2.0),
oropharynx (1.9) and lung (1.4), and for patients with
oropharyngeal cancer for subsequent cancers in the
oropharynx (SIR 5.8), lip (3.5) and lung (1.8), and for
leukaemia (2.3). Patients with oropharyngeal cancer also
showed elevated SIRs for lymphomas and cancers of the
colon and thyroid, although the numbers of patients were
small. Patients with lip or oropharyngeal cancer had an
elevated risk for cancer of the oesophagus (1.2 and 1.4
respectively). The SIRs for cancers at different sites are
shown in Table III.
More than half of the excess of the total cancer risk was
attributable to lung cancer. The SIR for lung cancer varied
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Table I Numbers of patients with lip and oropharyngeal cancer diagnosed
betwetn 1953 and 1989 in Finland, by sex and subsite
Number ofpatients/person-years
Primary site (ICD-7) Men Women Total
Lip (140) 4,972/47,118 661/ 4,833 5,633/51,951
Oropharynxa 1,908/ 7,639 1,551/ 8,126 3,459/15,764
Tongue (141) 624/ 2,768 604/ 3,404 1,228/ 6,172
Oral cavity (143-144) 626/ 3,050 591/ 3,591 1,217/ 6,640
Pharynx (145,7,8)a 658/ 1,821 356/ 1,131 1,014/ 2,952
aNasopharynx (146) not included.
Table II Observed numbers of new cancers (at any site) (Obs) and standardised
incidence ratios (SIR) among patients (males and females) with lip and oropharyngeal
cancer diagnosed between 1953 and 1989 in Finland, by site and age at diagnosis of first
cancer
Age at diagnosis offirst cancer
Site offirst 0-49 50+ Total
cancer Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
Lip 135 1.6 1.4 -1.9 766 1.1 1.0 -1.2 901 1.2 1.1 -1.3
Oropharynx 32 1.7 1.1 -2.4 197 1.3 1.1 -1.5 229 1.4 1.2 -1.6
Tongue 17 2.6 1.5 -4.1 89 1.5 1.2 -1.8 106 1.6 1.3 -1.9
Oral cavity 12 1.2 0.63-2.1 68 1.2 0.92-1.5 80 1.2 0.98-1.5
Pharynx 3 1.0 0.21-3.0 40 1.3 0.92-1.7 43 1.3 1.0 -1.7
CI, confidence interval.
Table III Observed (Obs) and expected numbers (Exp) of cases and standardised incidence ratios
(SIR) of subsequent cancer among patients (males and females) with lip and oropharyngeal cancer
diagnosed between 1953 and 1989 in Finland, by site
Site offirst primary
Site of second Lip Oropharynx
cancer (ICD-7) Obs SIR 95% CI Obs SIR 95% CI
All cancers (140-204) 901 1.2 1.1 -1.3 229 1.4 1.2 -1.6
Lip (140) 4 0.28 0.08-0.70 8 3.5 1.5 -6.9
Oral cavity, tongue, pharynx 16 1.9 1.1 -3.1 11 5.8 2.8 -10
(141, 143-5, 7, 8)
Oesophagus (150) 18 1.2 0.69-1.8 5 1.4 0.44-3.2
Stomach (151) 107 1.1 0.90-1.3 18 0.73 0.43-1.1
Colon (153) 26 0.81 0.53-1.2 13 1.5 0.80-2.6
Rectum (154) 30 0.99 0.67-1.4 7 1.0 0.40-2.1
Larynx (161) 23 2.0 1.2 -2.9 1 0.54 0.01-3.0
Lung (162) 269 1.4 1.3 -1.6 52 1.8 1.3 -2.3
Kidney (180) 9 0.47 0.22-0.90 5 1.1 0.37-2.7
Bladder (181) 38 1.0 0.73-1.4 8 1.3 0.55-2.5
Thyroid (194) 2 0.61 0.07-2.2 3 2.2 0.46-6.5
NHL (200, 202) 9 0.82 0.38-1.6 4 1.5 0.41-3.9
Hodgkin's disease (201) 3 0.96 0.20-2.8 2 2.7 0.33-9.8
Leukaemia (204) 13 0.74 0.39-1.2 9 2.3 1.0 -4.3
CI, confidence interval; NHL, non-Hodgkin's lymphoma.
from 1.4 among lip cancer patients to 2.0 among patients
with cancer of the pharynx (Table IV). The SIR was less
increased during the first years of follow-up than later on.
Among lip cancer patients the excess risk of lung cancer was
seen only after the mid-1960s. The relative risk of second
cancers among patients with oropharyngeal cancer did not
change by calendar period.
Radiotherapy constituted part of the treatment regimen in
4,815 (53%) of the patients (lip 41%, tongue 69%, oral
cavity 65%, pharynx 83%). Radiotherapy did not increase
the risk of a second primary; the relative risks were actually
lower for patients who had received radiotherapy than for
the others (Table V). No excess risks of leukaemia or cancers
close to the radiotherapy field were seen in patients treated
with radiotherapy, nor did the risk increase with time of
follow-up.
Discussion
National cancer registries constitute ideal sources of material
for studies on the risk of multiple primary neoplasms, since
both the observed numbers of new cancers and the expected
numbers relate to the same set of data (Schoenberg & Myers,
1977). The data in the Finnish Cancer Registry can be con-
sidered virtually complete in relation to coverage of cancers
diagnosed in Finland (Saxen & Teppo, 1978). Several studies
from the Finnish Cancer Registry on the risk of multiple
cancer have indicated that if no aetiological or other reasons
for increased or decreased risk exist, risk ratios calculated
have, in fact, been close to unity (Teppo et al., 1985).
New primaries are not always easy to distinguish from late
recurrences or metastatic lesions. Problems can occur when
the histological types of two tumours are similar. The low786 A.-L. SODERHOLM et al.
Table IV Observed numbers of lung cancer as second primary (Obs) and standardised
incidence ratios (SIR) among patients (males and females) with oropharyngeal cancer
(first primary diagnosed between 1953 and 1989 in Finland), by site of first cancer and
follow-up time
Follow-up (years)
Site offirst 0-4 5 + Total
cancer Obs SIR 95% CI Obs SIR 95% CI Obs SIR 95% CI
Lip 83 1.1 0.91-1.4 186 1.6 1.4 -1.8 269 1.4 1.3 -1.6
Oropharynx 23 1.5 0.98-2.3 29 2.0 1.3 -2.8 52 1.8 1.3 -2.3
Tongue 8 1.6 0.67-3.0 12 2.2 1.1 -3.8 20 1.9 1.1 -2.9
Oral cavity 9 1.6 0.73-3.0 9 1.5 0.67-2.8 18 1.5 0.91-2.4
Pharynx 6 1.5 0.53-3.2 8 2.6 1.1 -5.2 14 2.0 1.1 -3.3
Table V Observed numbers of new cancers (at all sites) (Obs) and
standardised incidence ratios (SIR) among patients (males and females) with
lip and oropharyngeal cancer diagnosed in Finland between 1953 and 1989, by
treatment
Type of treatment
With radiotherapy Without radiotherapy
Site offirst cancer Obs SIR 95% CI Obs SIR 95% CI
Lip 442 1.1 1.0 -1.3 459 1.2 1.1 -1.3
Oropharynx 147 1.3 1.1 -1.5 82 1.5 1.2 -1.9
Tongue 63 1.5 1.2 -2.0 43 1.7 1.2 -2.3
Oral cavity 50 1.1 0.83-1.5 30 1.3 0.88-1.9
Phaynx 34 1.2 0.85-1.7 9 1.4 0.64-2.7
relative risk of a subsequent new cancer at the site of the first
cancer in this series (0.3 for lip/lip, nil for tongue/tongue and
pharynx/pharynx) indicates that the Cancer Registry coding
has been reliable. The relative risk of a second primary in the
lung, 28% of all observed second cancers in this study, was
only slightly increased during the first 5 years ofall follow-up
but then stabilised at about 1.7. This may reflect the conser-
vative coding policy at the Finnish Cancer Registry: when-
ever there is reason to believe that a cancer in the lungs could
be a metastasis of an earlier cancer, it is not likely to be
coded as a new primary.
This comparatively large patient series confirms an
elevated risk of a second cancer in patients with cancer of the
lip or oropharynx, in agreement with findings in earlier
studies (Lindqvist et al., 1979; Tepperman & Fitzpatrick,
1981; Shikhani et al., 1986; Shibuya et al., 1987; de Vries &
Gluckman, 1991). However, the risk ratios reported in the
literature vary substantially, partly because of different
criteria for coding a second cancer. The problems of defining
the 'correct' order of diagnosis of synchronous tumours and
difficulties in reliably calculating the expected numbers of
cases resulted in a decision to exclude synchronous cancers
from the analysis reported here.
The excess risks among oropharyngeal cancer patients
found in this series for a second cancer of the oropharynx
(SIR 5.8), larynx (0.5) and lung (1.8) were markedly lower
than those (58, 7.3 and 7.0 respectively) reported by Shibuya
et al. (1987), or the 4- to 7-fold increases of respiratory
cancers reported by Day and Blot (1992) in a large
population-based series from several cancer registries in the
United States. Only a slight excess risk (SIR 1.4) was found
for cancer of the oesophagus among oropharyngeal cancer
patients in this series, in contrast to the SIR of 12 reported
by Shibuya et al. (1987).
The concentration of the excess risk of second cancer in
the oropharyngeal area, larynx and lung for lip cancer
patients and in the lip, oropharynx and lung for patients with
oropharyngeal cancer suggests a common, slowly acting risk
factor in the aetiology of these cancers, and supports the
widely accepted assumption that this factor is tobacco
(Wynder et al., 1977; Lyons et al., 1986; de Vries & Gluck-
man, 1991; Day & Blot, 1992). In the aetiology of lip cancer
outdoor occupation (effects of wind and/or UV radiation)
has also been considered an important risk factor (Lindqvist
et al., 1979), and a role for herpes simplex virus has been
suggested (Blomqvist et al., 1991). The significant excess risk
of lung cancer in this large series of lip cancer patients
supports the role of smoking as a risk factor for lip cancer.
Smoking and drinking together have been estimated to
increase the risk of oral cancer in the United States 3- to
5-fold (Blot et al., 1988). Even though the drinking habits in
Finland may result in somewhat lower risks than in the USA,
it is likely that, besides smoking, alcohol (known to be
associated with increased risk of cancers of the oral cavity,
pharynx, oesophagus and larynx) and possible interactions
between alcohol consumption and smoking could partly ex-
plain the excess risks recorded for second cancers at
numerous sites for patients with oropharyngeal cancer in this
series. However, the pattern of elevated SIRs did not suggest
alcohol aetiology to be clearly more important than smoking.
There were no significant excess risks for some alcohol-
related second cancers (e.g. oesophageal and laryngeal
cancers) among oropharyngeal cancer patients. The variation
in the relative risk by subsite and sex is likely to support a
multifactorial aetiology for oropharyngeal cancer.
The cancer risk pattern observed for lip cancer patients
reflects the general socioeconomic variation in cancer risk in
Finland. The risk of lip cancer increases markedly from the
higher to lower classes (Pukkala et al., 1993). Lip cancer
patients thus have an economic status below the Finnish
average. Since we used national average incidence rates as
reference values instead of those of the same social class, the
expected numbers of cases of subsequent cancers associated
with high social classes (colon, rectum, kidney, female lung
cancer, etc.; Rimpela & Pukkala, 1987) among lip cancer
patients are somewhat too high and those for cancers most
frequent among low-income groups (stomach, oesophagus,
male lung cancer, etc.) somewhat too low. The SIRs for
second cancers of the colon (0.8) kidney (0.5), stomach (1.1)
and lung (1.4) among lip cancer patients may therefore have
been close to 1.0 had it been possible to adjust for socio-
economic status. The incidence rates of cancers of the
tongue, oral cavity and pharynx do not vary by socio-
economic class to such an extent that it would have caused
any marked bias in the SIRs (Pukkala et al., 1993).
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under 50 years of age at the time of diagnosis of the first
cancer. In this group, patients with cancer of the lip or
tongue experienced a greater excess risk of new primary
cancer than did older patients. This may indicate a genetic
susceptibility to cancer in such patients.
Chemotherapy and radiotherapy are potentially car-
cinogenic (Arseneau et al., 1977; Boice & Hutchinson, 1980;
Newton et al., 1991). In our study the risk of a second cancer
in patients who had received radiotherapy for oropharyngeal
cancer was not higher than that in those who had not been
given radiotherapy. Chemotherapy has been used in Finland
for treatment of these cancers to such a limited extent
(Soderholm et al., 1991) that no risk evaluation was possible.
The results of our study do not give any reason to restrict
the use of radiotherapy if considered useful for the treatment
of the cancers of the lip, tongue, oral cavity and pharynx.
The excess risks found do not support the idea of routine
panendoscopic examinations of the aerodigestive and res-
piratory tracts of patients with treated oropharyngeal cancer
as suggested by many authors. A follow-up regimen of
clinical examinations and chest radiographs on a yearly basis
continuing for more than 5 years would be sufficient.
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